| <img alt="" height="1" width="1" />Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial ...MarketWatch (press release)The proceeds will be used to fund a Phase 3 clinical trial for asimadoline for the treatment of patients with diarrhea predominant Irritable Bowel Syndrome ...<nobr></nobr> |
Google- Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial ... - MarketWatch (press release)
Join the discussion
